Disparities in the initial presentation of differentiated thyroid cancer in a large public hospital and adjoining university teaching hospital

Thyroid

Volumn 22, Issue 3, 2012, Pages 269-274

  Lim, Irene Isabel Payad ^a   Hochman, Tsivia ^b   Blumberg, Sheila Nafula ^a   Patel, Kepal Narendra ^a   Heller, Keith Stuart ^a   Ogilvie, Jennifer Braemar ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR DIFFERENTIATION; UNIVERSITY HOSPITAL;

ADENOCARCINOMA, FOLLICULAR; ADENOCARCINOMA, PAPILLARY; ADENOMA, OXYPHILIC; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DEMOGRAPHY; FEMALE; HEALTHCARE DISPARITIES; HOSPITALS, PUBLIC; HOSPITALS, UNIVERSITY; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; MALE; MIDDLE AGED; NEOPLASM STAGING; NEW YORK CITY; RETROSPECTIVE STUDIES; THYROID NEOPLASMS;

EID: 84857819309     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2010.0385     Document Type: Article

References (25)

1. Gilliland FD, Hunt WC, Morris DM, Key CR 1997 Prognostic factors for thyroid carcinoma. A populationbased study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 79:564-573.
2. Bernet V 2010 Approach to the patient with incidental papillary microcarcinoma. J Clin Endocrinol Metab 95:3586-3592.
3. Tuttle RM, Leboeuf R 2008 Follow up approaches in thyroid cancer: A risk adapted paradigm. Endocrinol Metab Clin North Am 37:419-435.
4. Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM, Travagli JP, Schlumberger M 2005 Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90:5723-5729.
5. Morris LG, Myssiorek D 2010 Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: A population-based analysis. Am J Surg 200:454-461.
6. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167.
7. Chen AY, Jemal A, Ward EM 2009 Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 115:3801-3807.
8. Rego-Iraeta A, Perez-Mendez LF, Mantinan B, Garcia-Mayor RV 2009 Time trends for thyroid cancer in northwestern Spain: True rise in the incidence of micro and larger forms of papillary thyroid carcinoma. Thyroid 19:333-340.
9. Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY 2008 Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: A retrospective analysis. Lancet Oncol 9:222-231.
10. Yorio JT, Xie Y, Yan J, Gerber DE 2009 Lung cancer diagnostic and treatment intervals in the United States: A health care disparity? J Thorac Oncol 4:1322-1330.
11. Howlader N, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (eds) 2011 SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda.
12. Yu GP, Li JC, Branovan D, McCormick S, Schantz SP 2010 Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ ethnicity groups. Thyroid 20:465-473.
13. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS 2009 Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 18:784-791.
14. Siegel B 1996 Re-engineering the public hospital system: Saving the safety net. Bull NY Acad Med 73:357-369.
15. Weiss E, Haslanger K, Cantor JC 2001 Accessibility of primary care services in safety net clinics in New York City. Am J Public Health 91:1240-1245.
16. Greene FL 2002 American Joint Committee on Cancer 2002. AJCC cancer staging manual, 6th edition. Springer-Verlag, New York.
17. Sandman DR 1999 Health care in New York City: Understanding and shaping change. Issue Brief (Commonw Fund) 349:1-9.
18. Haynes R, Pearce J, Barnett R 2008 Cancer survival in New Zealand: Ethnic, social and geographical inequalities. Soc Sci Med 67:928-937.
19. Sosa JA, Mehta PJ, Wang TS, Yeo HL, Roman SA 2007 Racial disparities in clinical and economic outcomes from thyroidectomy. Ann Surg 246:1083-1091.
20. Bilimoria KY, Bentrem DJ, Linn JG, Freel A, Yeh JJ, Stewart AK, Winchester DP, Ko CY, Talamonti MS, Sturgeon C 2007 Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery 142:906-913.
21. Kus LH, Shah M, Eski S, Walfish PG, Freeman JL 2010 Thyroid cancer outcomes in Filipino patients. Arch Otolaryngol Head Neck Surg 136:138-142.
22. Clark JR, Eski SJ, Freeman JL 2006 Risk of malignancy in Filipinos with thyroid nodules-a matched pair analysis. Head Neck 28:427-431.
23. Rossing MA, Schwartz SM, Weiss NS 1995 Thyroid cancer incidence in Asian migrants to the United States and their descendants. Cancer Causes Control 6:439-444.
24. Kolonel LN, Hankin JH, Wilkens LR, Fukunaga FH, Hinds MW 1990 An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control 1:223-234.
25. Ashing-Giwa KT, Gonzalez P, Lim JW, Chung C, Paz B, Somlo G, Wakabayashi MT 2010 Diagnostic and therapeutic delays among a multiethnic sample of breast and cervical cancer survivors. Cancer 116:3195-3204.